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Summary 
We investigated whether human resting T cells could be activated to proliferate and display effector 
function in the absence of T cell receptor occupancy. We report that combination of interleukin 2 
(IL-2),  tumor  necrosis  factor or,  and IL-6 activated highly purified naive  (CD45RA +)  and 
memory (CD45RO +)  resting CD4 +  T  cells  to proliferate.  Under  this condition, memory 
resting T  cells could also display effector function as measured by lymphokine synthesis and 
help for immunoglobulin production by B cells. This novel Ag-independent pathway of T cell 
activation may play an important role in vivo in recruiting effector T cells at the site of immune 
response and in maintaining the clonal size of memory T cells in the absence of antigenic stimulation. 
Moreover, cytokines can induce proliferation of naive T cells without switch to memory phenotype 
and this may help the maintenance of the peripheral pool of naive T  cells. 
I 
t is well known that activation of resting T cells, in vivo, 
generally results  from  the  occupancy of the  TCR  by 
immunogenic peptides bound to MHC molecules. However, 
there is circumstantial evidence that at infection sites in vivo 
many more T cells are activated, as measured by mRNA for 
lymphokines,  than  would be  expected  to  be  responding 
specifically  to  pathogens  (1). Little is  known  about  the 
activation mechanisms leading to nonspecific recruitment, i.e., 
the discrepancy  in frequencies between activated and Ag- 
specific T  cells  (2). 
The experiments presented here were aimed at assessing 
whether cytokine(s) secreted  during Ag-specific  activation 
could in turn activate bystander resting T  cells that are not 
specific for the stimulating Ag. This study was prompted 
by the observation that highly purified resting CD4 + T cells 
could be activated to proliferate in the presence of supernatants 
from  Ag-stimulated  T  cell  clones.  Here  we  report  that 
combination of IL-2, TNF-c~,  and IL-6 can activate highly 
purified naive (CD45RA +) and memory (CD45RO +) rest- 
ing CD4 + T  cells to express  activation markers, enter the 
cell cycle, and proliferate.  Furthermore, memory resting T 
cells  could  also  display  effector function as  measured by 
lymphokine synthesis and help for Ig production by B cells. 
Materials and Methods 
Purification of Resting T Cells.  After Ficoll-Hypaque  (Pharmacia, 
Uppsala, Sweden) separation of  PBMC from buffy coats of  healthy 
donors, most macrophages were removed by plastic adherence. To 
obtain  a pure resting  CD4 + T  cell population,  cells were in- 
cubated with a cocktail ofmAbs against HLA-DIL (L-243; Amer- 
ican Type Culture Collection [ATCC], tLockville, MD),  CD19 
(4G7), CD16 (B73.1), CD56  (MY31), CD57  (HNK-1, ATCC), 
CD8 (OKT8, ATCC), CD11b (OKM-1, ATCC), CD14 (MO-P9), 
TCR-~//~ (B1, a gift of G. De Libero, ZLF Basel, Switzerland), 
CD25 (2A3), CD69 (L78), and CD71 (L01.1). After 30-rain incu- 
bation on ice, cells were washed twice and incubated with mag- 
netic beads (Dynabeads; Dynal, Oslo, Norway) conjugated with 
goat anti-mouse IgG and rat anti-mouse IgM, at a 1:4 target/bead 
ratio. After 30-rain incubation, bead-bound  cells  were removed  using 
rare earth magnet (Advanced Magnetics, Inc., Cambridge, MA). 
Remaining cells were further purified with four more incubations 
with beads at increasing target/bead ratios (1:10 to 1:100). Final 
population was used as a source of resting CD4 § T cells when 
>99.3% of the population was TCR-c~//5  § (WT/31) and CD4 + 
(Leu 3a), as determined by immunofluorescence analyses using a 
FACScan  |  flow cytometer (Becton Dickinson & Co., Mountain 
View, CA~, and fulfilled the following criteria: (a) small size at 
the FACS  ~ scatter; (b) absence of FACS|  levels of the 
activation markers CD69, CD71, MHC-DR, and IL-2 receptor p55 
chain (CD25); (c) absence of cells in the S and G2/M parts of the 
cell cycle; and (d) no significant incorporation of [3H]thymidine 
when exposed to IL-2. In some experiments, resting cells were fur- 
ther negatively sorted as CD45ILO-  (adding the mAb UCHbl) 
or CD45RA- (adding the mAb L48). If not otherwise indicated, 
all the mAbs were from Becton Dickinson & Co. 
Pre~ration of Supernatants.  T cells (5  x  10S/ml) from a tetanus 
toxoid (TT)-specific clone were cultured with autologous macro- 
phages (2.5  x  l@/ml) that had been prepulsed with or without 
TT (3 gg/ml) (Biocine Sclavo, Siena, Italy). After 16 h, superna- 
tants were collected  and filtered  with 0.2-~tm  falters.  Culture medium 
has been previously  described (3) using 5% human serum or plasma. 
Effective  supernatants  were prepared using medium with either 5% 
human serum (from Florence blood bank) or serum-free media 
(HL-1; Ventrex, Portland, OIL). Similar  results were obtained with 
resting T cells derived  from PBMC of six different healthy individ- 
uals and with supernatants from activated CD4 § T cell clones, 
with different specificity  (purified  protein derivative [PPD] or per- 
tussis toxin), from four different persons (see Fig. 2 and data not 
shown). 
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propidium iodide in combination with anti-CD4 mAb (FITC la- 
beled) staining. Analyses were performed with the FACScan |  Lysis 
II software and doublet discrimination program (Becton Dickinson 
& Co.). 
Purification of  B Cells.  PBMC-derived B cells were stained with 
FITC-labeled anti-CD19 mAb and purified by positive sorting with 
FACStar  |  (Becton Dickinson & Co.). Purity was >98% as deter- 
mined by staining with  anti-CD20  and anti-Ig. 
Helper Assay.  Noncognate helper assays were performed as pre- 
viously described (5). Briefly, purified autologous PBMC-derived 
B  cells  (2  x  103/well)  were  cocultured  for  12  d  with 
CD4+CD45RO + resting T  cells (3  x  104/well)  in the presence 
of cytokine  combinations  as  described  (see  Fig.  3)  or on  anti- 
CD3-coated plates. To avoid an effect ofcytokines on B cell differen- 
tiation, plates were washed after 4-d culture and cytokine combi- 
nations were replaced with IL-2 alone. Ig in the supernatants was 
measured by ELISA (5). 
Activation of  Resting T Cells by Supematants.  Resting T cells were 
cultured in 96-well flat-bottom plates (5  x  104/well) with super- 
natant (50% vol/vol) from T cell clones cultured with autologous 
macrophages prepulsed with Ag, medium, or rlL2 (Cetus Corp., 
Emeryville, CA) at a concentration corresponding to that found 
in the T  cell supernatants  (i.e.,  200-300  U/ml).  Activation was 
measured at various time points as expression of CD69 and CD25 
or [3H]thymidine incorporation. In some experiments, [~H]thymi- 
dine incorporation of resting CD45RO § or CD45RA § T  cells 
was measured in the presence of different concentrations of IL-2 
plus either 1/zg/ml LPS (Difco, Detroit, MI) or supernatant (50% 
vol/vol) from LPS-activated macrophages. For the preparation of 
activated macrophage supernatant,  5  x  105 macrophages were 
simulated with  1/xg/ml LPS (for 6-8 h).  [3H]Thymidine incor- 
poration experiments were performed as described (5). The results 
represent the mean of triplicate wells  and SD was always  15%. 
Activation of  Resting T Cells by Recombinant  Cytokines.  Resting 
T cells (5  x  10~/welI) in 96-well flat-bottom microplates were cul- 
tured for 8 d with various combinations of the following: rlL-2 
(200-300 U/ml), rlL-6 (500 U/ml; Ciba-Geigy, Basel, Switzerland; 
IL-6 units were determined with the B9 assay), TNF-c~ (25 ng/ml; 
Genzyme Corp., Cambridge, MA), and supernatant (50% vol/vol) 
from LPS-stimulated macrophages. Thymidine incorporation and 
CD69 expression were measured as described in Fig. 2. IL-lb (up 
to 100 ng/ml,  Biocine Sclavo Siena,  Italy) in combination with 
IL-2 and  TNF-o~  did  not  have  any activities  (data not  shown). 
Recombinant cytokines from two different sources have been used 
with similar results.  The optimal concentration of cytokines was 
established in preliminary dose-response experiments. 
PCR-assisted mRNA  Amplification.  Purified  resting  CD4 + 
CD45RO + T cells were cultured with TNF-cr  plus Ib6 plus IL-2, 
or I~2 alone.  Total RNA was isolated after 60-100 h of culture 
from  5  x  l0  s  cells,  by  RNAzol  TM  B  (Biotecx  Laboratories, 
Houston, TX). cDNA was synthesized with murine reverse tran- 
scriptase as described (5)./~-actin, IL-4, and IFN-'y specific primer 
pairs were purchased from Clontech  (Palo Alto, CA). PCR was 
performed as described  (5). 
Limiting l~'lution Analyses.  CD45RO + resting  T  cells were 
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Figure  1.  Phenotypic and  cell 
cycle analysis of purified CD4 + 
resting T cells. (A) Forward and side 
scatter profile. (B) Cell cycle anal- 
ysis. (C) FITC- or PE-conjugated 
control antibodies. (D-F) Purity of 
CD4 + cells and expression of ac- 
tivation markers. (G) Expression  of 
CD45RA and CD45RO Ags on 
sorted  CD4 +  cells. (H  and  /) 
CD4 + ceils purified as CD45RO + 
or CD45RA + subpopulations. 60- 
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Figure 2.  Activation of resting CD4*  T cells by soluble factors. (A 
and B) Expression of activation markers on resting T cells cultured with 
supernatant from T cell clones cultured with autologous macrophages 
prepulsed with Ag (hatched bars) or medium (solid bars), or rib2 (open bars). 
Expression of CD69 or CD25 was analyzed in double staining with anti- 
CD4. (C) [3H]Thymidine incorporation of the same cells in A and B, 
cultured with medium alone (triangles), rlL-2 (squares), or supernatant from 
a T cell clone cultured with macrophages prepulsed with Ag (closed circle) 
or medium  (open circle). (D)  [3H]Thymidine incorporation  of resting 
CD45KO + (squares) or CD45RA + (circles) T  cells in the presence of 
different concentration of Ib2 plus 1 #g/ml LPS (open symbols),  or IL-2 
with supernatant from LPS-activated macrophages (closed symbols). 
plated at different numbers in Terasaki plates (64 wells per condi- 
tion) in 20 #1 vol in the presence of purified autologous irradiated 
(2,500 tad) macrophages (3  x  103/well),  anti-DR mAb (L243, 
20 #g/ml) with II,2 alone (300  U/ml) or in combination with 
TNF-c~ (25 ng/ml) and IL-6 (500 U/ml). On day 14, cultures were 
visually inspected for growth. Randomly selected  growing wells 
were positively stained with anti-CD4 and anti-TCK-ot/~ antibodies. 
Frequency analyses  were done by the least squared method (6). 
Results and Discussion 
A  critical point of this study was to use a resting popula- 
tion devoid of activated T  cells that would respond to IL-2 
alone.  We  chose  to  work  with  resting  CD4 §  T  cells be- 
cause,  at  variance with  some  CD8 +  or "y/6  T  cells  with 
resting phenotype,  they do not  express IL-2 receptor p75- 
chain in the absence of the p55-chain (7), which may be respon- 
sible for unwanted proliferative responses to IL-2 (8) and for 
which we did not have a good antibody to sort out. We there- 
fore performed muhistep exhaustive purifications  to obtain 
| 
CD45RO+T CELL 
PROLIFERATION 
( cpm ) 
14500 
11200 1 
7900 t 
4400 t 
1200 
| 
CD45RA+T CELL 
PROLIFERATION 
( cpm ) 
15500 
15000 ~f,J 
300  I~/.  ~ 
700 y~ 
200 
@ 
CD69 
kL 
CD69 
10 
m 
--  S 
O 
==s 
O  >, 
o  4 
o~ 
2 
"D 
2  3  4  5  6  7  8 
Days 
STAINED CELLS 
(%) 
74  TNF + IL6 + IL2 
48  MO SUP + IL2 
41  TNF + IL2 
6  IL6  + IL2 
IL2 
STAINED CELLS 
(%) 
73  TNF + IL6 +IL2 
58  MiD  SUP+ IL2 
2  I'NF + IL2 
4  [L6  + IL2 
1  [L2 
Figure  3.  Combination of IL-2, TNF-o~, and II-,6 activates resting T 
ceils. CD45RO + (A) or CD45RA + (B) resting T cells were cultured for 
8 d with various combinations of the following: rlL-2, rlL-6, TNF-~, and 
supernatant from LPS-stimulated macrophages. Thymidine incorporation 
and CD69 expression were measured as described in Fig. 1. (C) Cell cycle 
analyses of resting CD45RO + (squares) or CD45RA + (circles) T cells in 
the presence of IL-2 alone (open symbols) or in combination with TNF-c~ 
and IL-6 (closed symbols). 
highly purified resting CD4 § T  cells from PBMC (Fig.  1). 
In preliminary experiments, resting CD4 + T  cells were cul- 
tured with supernatants from CD4 § T  cell clones that had 
been activated by Ag-pulsed macrophages. A  representative 
experiment in Fig. 2 shows that a fraction of resting CD4 + 
T  cells is activated by the  supernatant,  but not by IL-2, to 
express CD69 (9) (Fig. 2 A) and IL-2 receptor p55-chain (Fig. 
2  B),  and  to incorporate  [3H]thymidine  (Fig.  2  C). 
Since the activating supernatant is produced by the cocul- 
ture of two cell types, we sought to determine the relative 
contribution of soluble factors produced by T cells and APCs. 
For  this  experiment,  resting  CD4 +  T  cells  were  further 
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subpopulations (10), since they may have different activation 
requirements as already reported for TCR-mediated activa- 
tion (11, 12). Fig.  2 D  shows that supernatant from LPS- 
activated macrophages alone, as IL-2 alone, did not have any 
activity, whereas macrophage supernatant in combination with 
IL-2 induced thymidine incorporation in both CD45RA + 
and CD45RO + resting T  cells. These results demonstrate 
that IL-2 and soluble factor(s) produced by APCs are required 
for the activation of resting T  cells. 
To identify the APC-derived factor(s), we tested the effect 
of recombinant cytokines known to be produced by macro- 
phages and to have costimulatory activity on T cells, i.e., IL- 
lfl, IL-6, and TNF-ot (13-15).  In the absence  of IL-2, all 
the possible  combinations of these cytokines did not show 
any activity over a wide range of concentrations (data not 
shown). Fig. 3 A  shows that TNF-ot in combination with 
IL-2 induced resting CD45RO §  T  cells to express  CD69 
and to incorporate thymidine, whereas IL-6 in combination 
with IL-2 was much less effective. Remarkably, TNF-ot and 
IL-6, in combination with IL-2, had a synergistic effect leading 
to a stronger activation. A similar effect of IL-2, IL-6, and 
TNFot was also observed on CD45RA § resting T cells (Fig. 
3 B), although, in this case, all three cytokines were required 
to induce activation. Furthermore, the cell cycle analyses in 
Fig.  3  C  show  that  at  day 8  of culture,  '~8%  of both 
CD45RO + and CD45RA + T  cells are in the S or G2/M 
phases  of the cell cycle. Activation by cytokines, measured 
as expression of activation markers, thymidine incorporation, 
or entry into cell cycle, was never inhibited by mAbs specific 
for DR, CD4, or CD3 (data not shown), thus confirming 
that TCR signaling is not involved in this type of activation. 
It  is  interesting  to  note  that  we  have  observed  that 
CD45RA +  T  cells  activated by cytokines do  not  switch 
their phenotype to CD45RO, as was reported to occur within 
a few days after TCR engagement (16). CD45RA + T  cells 
activated by combination of IL-2, TNF-ot,  and IL-6 were 
double stained with anti-CD45RA and anti-CD45RO anti- 
bodies at 3-d intervals up to day 23 of culture. We never found 
single positive CD45RO § cells at any time point, and only 
found  a  few  percent  of double  positive  CD45RA+high/ 
CD45RO+auL Indeed, Fig. 4 shows that naive T  cells even 
23  d  after cytokine activation, when most cells are blastic 
and express CD69 (data not shown), are mainly CD45RA +  . 
The same cells activated with anti-CD3 switched in few days 
to the CD45RO § CD45RA- phenotype (data not shown). 
We next asked whether resting T  lymphocytes can be ac- 
tivated by cytokines to display effector function. We performed 
PCR-assisted mRNA amplification for lymphokines. Fig. 5 
shows that both IFN-'y and IL-4 mRNA are expressed by 
CD45RO + T  cells cultured with IL-2, TNF-cz, and IL-6, 
but not with IL-2 alone.  Moreover,  CD45RO + T  cells ac- 
tivated  by  cytokine combination  are  as  effective  as  anti- 
CD3-stimulated T cells in helping B cells to produce Ig (Table 
1). To exclude the possibility that T cell help to B cells could 
be due to activation of autoreactive cells, at the end of the 
helper assay, the B cells were removed by sorting, and the 
o 
re 
r 
O 
10  3 
10  2 
10 ~ 
0%  <0.2% 
10  ~  10  2  10  3 
CD45RA 
101  10  2  10  3 
Figure  4.  CD45RA + T cells activated by cytokines do not switch their 
phenotype to CD45RO. CD45RA § T cells were activated by combina- 
tion of IL-2, TNF-a, and IL-6, and after 23 days were double stained with 
anti-CD45RA-FITC and  anti-CD45RO-PE antibodies. 
CD4 § T cells were tested in proliferation  against autologous 
purified B cells or macrophages. We never found any autoreac- 
tive proliferation (data not shown). 
Neither cytokines nor anti-CD3 induced CD45RA §  T 
cells to produce IFN-3, (<1 IU/ml) and to help B cells (data 
not shown). Thus, we conclude that, similar to TCR-mediated 
activation  (17), cytokines  recruit  CD45RA +  T  cells  to 
proliferate but not to help Ig production, whereas they acti- 
vate resting  CD45RO + T  cells to  proliferate  and display 
effector functions. 
To evaluate the frequency of resting T cells with memory 
phenotype that could be stimulated by cytokines to grow, 
we  performed limiting dilution experiments.  CD45RO + 
CD4 + resting T  cells were cultured with IL-2 alone or in 
combination with TNF-ot and IL-6, in the presence of au- 
tologous irradiated macrophages and anti-DR antibodies to 
prevent autoreactive responses. Fig. 6 shows that 1 of 33 resting 
CD45RO + CD4 §  T  cells  grew  to  a visible  clone in re- 
sponse to IL-2, TNF-ot, and IL-6. At present we do not know 
why only 3%  of cells grew in response  to cytokines. The 
cells that proliferated could have been a subset of resting T 
cells or could have been at a different stage of maturation/acti- 
Figure  5.  Expression of IFNqr and Ib4 mRNA by cytokine-activated 
T cells. Purified CD4 +  CD45RO + resting T cells are cultured  with IL-2 
alone for 60 (lane I) and  100 h (lane 3) or with IL-2, TNF-cx, and IL-6 
for 60 (lane 2) and 100 h (lane 4) as described in Materials and Methods. 
(Lane 5) Positive template;  (lane 6) negative  control. 
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Can Provide Help to B  Cells 
IgM  IgG  IgA 
B cells cocultured  with: 
IL-2 plus TNF-c~ plus IL-6 
ng/ml 
<15  <5  <10 
T  cells plus medium  <15  <5  <10 
T  cells plus IL-2  <15  <5  <10 
T cells plus IL-2 plus TNF-cr  32  23  <10 
T  cells plus IL-2 plus IL-6  <15  31  28 
T  cells plus IL-2 plus TNF-a 
plus IL-6  75  274  308 
T  cells plus anti-CD3  mAb plus IL-2  235  219  413 
vation.  It  is  possible that  many cells  (=20%)  respond  to 
cytokines and express activation markers. Some of these cells 
will display effector functions and only a minority (3 %) will 
be able to  grow in vitro  to a clone of visible size. 
TNF-o~ and IL-6 both have been shown to upregulate IL- 
2R expression on T  cells (15,  18). This could be a possible 
mechanism for the activation of resting T cells by this cytokine 
combination. However, resting T cells cultured for 1-3 d with 
TNF-a and IL-6, and washed and cultured for 4-5 d more 
with IL-2, did not show FACS|  levels of IL-2R 
(p55)  (data not  shown),  whereas IL-2R was expressed on 
=20%  of the same cells  cultured with  TNF-o~,  IL-6,  and 
IL-2 from the beginning  of the culture.  This  experiment, 
however, does not rule out the possibility that low levels of 
IL-2R, below the FACS  |  sensitivity, are expressed and func- 
tionally relevant.  Indeed,  it has been reported  that  IL-2 is 
required for induction of IL-2R by TNF-ol or IL-6 (19). Fur- 
thermore,  IL-2  augments  not  only expression  of its  own 
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Figure  6.  Frequency  of resting 
T cells that grow in response to 
cytokine combination. CD45RO  + 
resting T cells were plated in the 
presence of purified autologous 
macrophages, anti-DR mAb with 
IL-2 alone (closed  circles) or in com- 
bination (open  circles) with TNF-c~ 
and  IL-6. (Dotted lines) 95% 
confidence limits. 
receptor (20) but also upregulates TNF-o~ receptor (21). Elu- 
cidation of the mechanism  of activation of resting  T  cells 
by cytokines will require additional biochemical and molec- 
ular analyses. 
This novel Ag-independent  pathway of T  cell activation 
may play two important roles in vivo, by recruiting effector 
T  cells at the site of immune response and by maintaining 
the peripheral pool of memory T  cells. A scenario could be 
depicted where resting T cells at sites of Ag-specific response 
are activated by cytokines produced by specific T  cells  and 
macrophages to proliferate and to secrete other lymphokines 
that can further amplify the response. Indeed, the frequency 
of resting CD45RO + T cells that respond to cytokine com- 
bination is definitely higher  than  the usual frequency of T 
cells  primed by any known Ags. 
It has been postulated that memory can be carried by long- 
lived clones consisting of short-lived cells that require repeated, 
intermittent  stimulation by persisting Ag, by recurrent  in- 
fection, or by cross-reacting environmental Ags (22-24). In 
the light of our results, it is tempting to speculate that memory 
T  cells may not require antigenic stimuli to maintain  their 
clonal  size,  since resting  T  cells  with  memory phenotype 
(CD45RO +) can be expanded by cytokines secreted during 
responses to unrelated antigens.  On the other hand, cytokines 
can  induce  proliferation  of naive  cells without  switch  to 
memory phenotype and may therefore help to maintain the 
naive (CD45RA +)  T  cell repertoire. 
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